Early detection of laryngeal cancer: prominence of miRNA signature as a new tool for clinicians
Submitted: 21 December 2016
Accepted: 26 January 2017
Published: 16 January 2017
Accepted: 26 January 2017
Abstract Views: 1525
PDF: 534
HTML: 921
HTML: 921
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Kawasaki, H., Zarone, M. R., Lombardi, A., Ricciardiello, F., Caraglia, M., & Misso, G. (2017). Early detection of laryngeal cancer: prominence of miRNA signature as a new tool for clinicians. Translational Medicine Reports, 1(1). https://doi.org/10.4081/tmr.6502
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.